Covid-19 Pharma News
Updated Moderna Covid Vaccine Effective Against New Variant
Moderna Inc announced that clinical trial data from its research assay confirm its updated COVID-19 vaccine. Read more
6 Sep 2023
MHRA Approves Pfizer/BioNTech’s Adapted COVID-19 Vaccine
Approval has today been granted by the Medicines and Healthcare products Regulatory Agency (MHRA) for an adapted Pfizer/BioNTech COVID-19 vaccine that targets the Omicron XBB 1.5 subvariant. Read more
6 Sep 2023
Regeneron and BARDA Collaborate on Next Generation Covid-19 Vaccines
Regeneron Pharmaceuticals have announced that the BARDA has entered into an agreement with Regeneron to support development, clinical manufacturing and the regulatory licensure process of a next-generation COVID-19 monoclonal antibody therapy. Read more
23 Aug 2023
Moderna Clinical Trial Confirms Updated Covid-19 Vaccine Generates Robust Immune Response
Late last week, Moderna, Inc announced that preliminary clinical trial data confirm its updated COVID-19 vaccine for the fall 2023 vaccination season showed a significant boost in neutralising antibodies against EG.5 and FL.1.5.1 variants. Read more
22 Aug 2023
Covid-19 Variants Detected in UK
The UK Health Security Agency (UKHSA) has published an initial risk assessment of the SARS-CoV-2 variant BA.2.86. Read more
21 Aug 2023
NIH and Exothera Produce GMP Intranasal Vaccine Against SARS-CoV-2 for Clinical Phase I/II Trial in Africa and US
The National Institutes of Health (NIH), the US’s medical research agency, selected Exothera S.A to develop the manufacturing process for NIH’s intranasal vaccine against SARS-CoV-2. Read more
16 Aug 2023
Moderna v Pfizer-BioNTech: Lessons to be learnt from post-pandemic disputes
Dr. Nicholas Jones, partner and patent attorney at Withers & Rogers, discusses what the pharma industry can learn from its experiences of working collaboratively during the COVID-19 pandemic by establishing best practice and minimising risks. Read more
13 Sep 2022
Using genomic sequencing to predict COVID’s next move
Brittany Niccum, Beckman Coulter Life Sciences, shares how genomic sequencing and laboratory automation can monitor new variants of COVID and potentially nip them in the bud, before they transform into future pandemics. Read more
17 Aug 2022
Wastewater is anything but a waste: It could even prevent the next pandemic
Ari Goldfarb, CEO, Kando, discusses how innovative technologies and artificial intelligence tools are advancing wastewater analysis and could potentially mitigate the effects, or even prevent, future pandemics. Read more
26 Jul 2022
Shutterstock
Otsuka and Astex Announce the European Commission has Approved INAQOVI
Otsuka Pharmaceutical Europe Ltd. and Astex Pharmaceuticals, Inc. have announce that the European Commission (EC) has approved INAQOVI. Read more
22 Sep 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
Shutterstock
Daiichi and AstraZeneca Breast Cancer Drug Hits Goal
Positive high-level results from the TROPION-Breast01 Phase III trial showed datopotamab deruxtecan (Dato-DXd) demonstrated a statistically significant and clinically meaningful improvement. Read more
22 Sep 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
Shutterstock
Samsung Biologics Announce Agreement with Bristol Myers Squibb to Manufacture an Antibody Cancer Drug Substance
Samsung Biologics announced today a new agreement with Bristol Myers Squibb for large-scale manufacturing of a Bristol Myers Squibb commercial antibody cancer drug substance. Read more
22 Sep 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
TurboFil Expands Development and Demonstration Facility
TurboFil Packaging Machines LLC has substantially expanded the product development and demonstration space at its Mount Vernon, NY headquarters. Read more
22 Sep 2023
Shutterstock
Evecxia Therapeutics and Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treatment
A partnership between Evecxia Therapeutics and Quotient Sciences has resulted in the successful delivery of a Phase 1 clinical testing program for Evecxia’s drug candidate EVX-101, which is in development for major depressive disorder. Read more
22 Sep 2023
Shutterstock
2San Partners With Phoenix Healthcare To Launch Self Diagnostic Tests In UK
2San is partnering with Phoenix Healthcare to allow independent pharmacies to stock an increased range of rapid self-diagnostic products. Read more
21 Sep 2023
Sponsored Content
Optimization of a bio-decontamination process: atomized hydrogen peroxide new cycle development method
Risk-based cycle development, considering not only the required decontamination level but the type of load and cycle total time Read more
3 Feb 2023
11:15
Sponsored Content
Optimization of a bio-decontamination process: atomized hydrogen peroxide new cycle development method
Risk-based cycle development, considering not only the required decontamination level but the type of load and cycle total time Read more
3 Feb 2023
11:15
Polyflon Technology Ltd
Polyflon specialises in high-purity, inert and ADI-free fluoropolymer tubing, connectors, valves and cleanroom produced tubing assemblies for pharmaceutical applications from lab research through to pilot plant operations. Read more
